Why the study?
Systolic blood pressure control is a critical aspect of managing Type 2 diabetes, which is associated with an increased risk of cardiovascular events, but the comparative effects of intensive versus standard control remained to be evaluated.
Does intensive systolic blood pressure control reduce major cardiovascular events in patients with Type 2 diabetes?
Does intensive systolic blood pressure control reduce major cardiovascular events in patients with Type 2 diabetes?
Intensive systolic blood pressure control (<120 mmHg) in patients with Type 2 diabetes significantly reduces major cardiovascular events but increases the risk of hyperkalemia and hypotension.
Answers are grounded in this paper and cite their sources.
Intensive SBP control may associate with better outcomes in T2D; leaves open confirmation by RCTs before practice change.
Background: Systolic blood pressure (SBP) control is a critical aspect of managing Type 2 diabetes, which is associated with an increased risk of cardiovascular events. This retrospective study compares the effects of intensive SBP control (targeting < 120 mmHg) versus standard SBP control (targeting < 140 mmHg) on cardiovascular outcomes, mortality, and adverse effects in Type 2 diabetes patients. Methods: A total of 500 patients with Type 2 diabetes were included, with 250 in the intensive control group and 250 in the standard control group. Cardiovascular outcomes (heart attacks, strokes, cardiovascular mortality), adverse effects (hypotension, hyperkalemia), and medication adherence were assessed. Cox proportional hazards regression was performed to evaluate the effect of intensive SBP control on cardiovascular risk. Results: The intensive control group showed a significantly lower incidence of heart attacks (4.8% vs. 7.2%, p=0.03), strokes (3.2% vs. 5.6%, p=0.02), and cardiovascular mortality (2.4% vs. 4.8%, p=0.04) compared to the standard control group. However, the intensive group had a higher incidence of hyperkalemia (3.6% vs. 1.2%, p=0.04) and symptomatic hypotension (5.6% vs. 3.2%, p=0.09). Cox regression analysis revealed a 21% reduced risk of major cardiovascular events in the intensive control group (HR = 0.79, 95% CI: 0.62-0.99, p=0.04). Conclusion: Intensive SBP control significantly reduces cardiovascular events and mortality in patients with Type 2 diabetes. However, the increased risk of hyperkalemia and hypotension suggests that careful monitoring and individualized treatment strategies are essential. Further prospective trials are needed to confirm these findings and refine management guidelines for patients with Type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Adil et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: